A day after apologising to future registrants for the confusion and uncertainty surrounding the registration assessment process the General Pharmaceutical Council (GPhC) has today announced that they have secured further test centre places in Scotland for the March registration assessment.
Announcing it via a written statement on their website, Duncan Rudkin, Chief Executive of the GPhC, said:
“We are pleased to confirm that Pearson VUE have now been able to secure further test centre places in Scotland for the March registration assessment. This means that Scottish candidates who want to sit the assessment in Scotland should be able to do so. We’re working with Pearson VUE to complete the allocation of the test centre places to these candidates by the end of this week and they should receive confirmation emails as soon as their booking has been updated.
“We’ve also worked alongside Pearson VUE to make sure that all candidates who had booked afternoon places in a small number of venues due to a technical glitch are rebooked into a new test centre place.
“We have contacted the remaining candidates who have not yet booked to offer our help in finding them a place. There are still test centre places available across England and in Wales, so we are confident that everyone who wants to sit in March will be able to do so. We are also responding directly to candidates who have contacted us with any concerns or questions, including about the location of their sitting.
“I would like to apologise again for the anxiety and inconvenience this has caused candidates. We are committed to reviewing the issues from this sitting and taking all possible steps to avoid these issues happening in the future.”
Pharmacy in Practice has requested a video interview with the GPhC to deliver feedback from the candidates who have written letters to the editor.
Has your life been impacted by the situation around the provisional registration process? We would really like to hear from you. If you answer the questions below and indicate that you give us permission we will publish your contribution as a letter to the editor.